Dr. Daniele Gilkes is assistant professor of oncology, as well as an assistant professor in chemical and molecular engineering at the Johns Hopkins University School of Medicine.
This is her first year as a BCRF grantee. Dr. Paul Macklin is an associate professor of intelligent systems engineering, and a member of the Melvin & Bren Simon Cancer Center at Indiana University.
He’s a BCRF grantee since 2014. Together, Drs. Gilkes and Macklin are part of a collaboration between the BCRF and JKTG Foundation that links computational scientists with biologists.
They recently talked to BCRF about their efforts to gain new insights into tumor growth, metastasis, and the mechanics of drug resistance.
The Jayne Koskinas Ted Giovanis Foundation for Health and Policy (JKTG Foundation) today announced funding to develop a prototype multiscale model designed to predict therapeutic responses of tumor ecosystems – a new frontier in breast cancer research.
The word “stakeholder” really bothers me particularly in the healthcare space. I’m struck by a quote by Ken Burns.
“The thing that I’ve learned is that there is no ‘them.’ This is what everybody does: make a distinction about ‘them.’ It’s just ‘us’.”
In racing, we measure this in lap times often down to the second or tenths of a second. A recent racing article provoked me to think about the pursuit of “the last tenth” of a second in improvement which is typically the toughest and most difficult to attain.